CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 88 enrolled
Drug / intervention
Norethindrone acetatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02353247
NCT02353247N/ACompleted
CompareCT.gov

Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

Norton Healthcare·interventional·Posted Feb 2, 2015·Updated Mar 16, 2022

In Brief

A clinical study evaluating Norethindrone acetate for Etonogestrel Contraceptive Implant, Bothersome Bleeding. Completed, enrolled 88 participants across 1 site.

Detailed Summary

The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEtonogestrel Contraceptive Implant, Bothersome Bleeding
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 2, 2015
Enrollment StartAug 1, 2015
Primary CompletionJun 29, 2017
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.4 years ago

Interventions

Norethindrone acetatedrug